Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03607565

A New Parameter Derived From DSA to Evaluate Cerebral Perfusion

The Association Between a New Parameter Derived From DSA and Outcomes in Cerebral Ischemia

Status
Recruiting
Phase
Study type
Observational
Enrollment
30,000 (estimated)
Sponsor
Xi'an No.3 Hospital · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This observational study focus on a new parameter of cerebral perfusion derived form digital substraction angiography.

Detailed description

Ischemic cerebrovascular disease is an important cause of death and disability in the world. Digital Subtraction Angiography (DSA) is the golden index for evaluating cerebral blood vessels. We introduced a new parameter derived from DSA to evaluate the perfusion to predict the outcomes in acute stroke with large vessel occlusion. To study the possible relationship between the new parameter of cerebral perfusion derived from DSA and outcomes in cerebral ischemia(modified Rankin Scale), we intend to retrospectively analyze the images derived from patients who undergone the DSA and follow-up outcomes(modified Rankin Scale).

Conditions

Timeline

Start date
2018-07-15
Primary completion
2028-07-15
Completion
2038-07-15
First posted
2018-07-31
Last updated
2023-09-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03607565. Inclusion in this directory is not an endorsement.